Quarterly Result14 May 2025, 07:42 pm
JB Chemicals & Pharmaceuticals Ltd Reports 10% Revenue Growth in Q4 FY25 to INR 949 Crores and 12% Growth in FY25 to INR 3918 Crores
AI Summary
JB Chemicals & Pharmaceuticals Ltd, one of the fastest growing pharmaceutical companies in India, announced its financial results for the quarter and year ended 31st March 2025. The company recorded a revenue of INR 949 crores in Q4 FY25, representing a 10% growth from INR 862 crores in Q4 FY24. The operating EBITDA improved by 15% to INR 240 crores in Q4 FY25. For the full year FY25, the company recorded a revenue of INR 3918 crores, a 12% growth from INR 3484 crores in FY24. The net profit increased by 19% to INR 660 crores in FY25.
Key Highlights
- Revenue growth of 10% in Q4 FY25 and 12% in FY25
- Operating EBITDA improvement of 15% in Q4 FY25
- Net profit growth of 19% in FY25
- Domestic business continues to be one of the fastest growing in IPM
- CDMO business bounced back strongly in the second half of FY25